Women more vulnerable to HIV infection during pregnancy and months after birth

Organisation: Position: Deadline Date: Location:

A study presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2018) found that women in two prevention studies were nearly three times more likely to become infected with HIV while they were pregnant, and four times as likely in the six months after giving birth, compared with the risk of HIV infection at other times.

Previous studies of whether pregnancy increases risk have been inconclusive: a 2014 meta-analysis found a 30% raised risk of HIV infection during pregnancy, but two studies in that analysis found almost double the risk while the others found no raised risk.

This study, which is much larger, confirms what has long been suspected: that pregnancy and breastfeeding are times of particular HIV infection risk for women. The researchers do not suggest a cause for the increased risk other than that hormonal changes while women are pregnant or lactating may make HIV infection more likely.

The study presented was an analysis of HIV infections in women who were taking part in two HIV prevention trials: Partners in Prevention and Partners PrEP. Both studies looked at preventing HIV transmission between long-term heterosexual partners of different HIV status: the first by giving aciclovir to suppress herpes virus (HSV-2) in the HIV-positive partner; the second by giving tenofovir, plus or minus emtricitabine, to the HIV-negative partner as PrEP (pre-exposure prophylaxis).

HSV-2 prophylaxis did not work, but in Partners PrEP HIV infections were cut by two-thirds in the partners taking PrEP and it remains one of the key pieces of evidence that supports the effectiveness of PrEP against heterosexual HIV transmission.

The present study looked at 2751 HIV-sero-different couples from the two studies where the woman was the HIV-negative partner and aged between 18 and 49, and the HIV-positive partner was not on antiretroviral therapy. It did include women randomised to PrEP in the Partners PrEP study, as there were infections in this group; a sensitivity analysis that excluded women randomised to PrEP found similar results.

It looked at the rate of HIV infection in women during early pregnancy (0 to 13 weeks), late pregnancy (14 weeks to birth) and in the first six months after giving birth (the “post-partum” period).

The average age of the women was 32. The average number of sex acts within the last months with the regular partner was four when women were neither pregnant nor post-partum; in women who were pregnant, both all sex and condomless sex were more frequent in early pregnancy but less so in late pregnancy and in the post-partum period.

In any one month, 24% of women said that they had had sex without a condom – 22% of the women were ever pregnant during their time included in the study, giving a pregnancy rate of 12.5 per 100 women per year, and there were a total of 686 pregnancies of which 426 resulted in live births (some women were pregnant at the time the study finished).

There were 82 new HIV infections among the women studied, with an overall annual HIV incidence of 1.62%. (These 82 infections excluded “unlinked” infections – ones coming from partners other than the main partner.)

HIV incidence was significantly raised during pregnancy and in the post-partum period. It was 1.25% a year in women who were neither pregnant or post-partum, 3.75% in early pregnancy, 7.02% in later pregnancy and 4.68% in the post-partum period. But because women had the least sex in the post-partum period, the rate of infection during that time was actually even higher than in pregnancy. The number of infections per 1000 sex acts was 1.05 for women not pregnant or post-partum, 2.19 in early pregnancy, 2.97 in late pregnancy, and 4.18 post-partum.

In a multivariate analysis, these figures were then adjusted for the viral load of the partner, age of the woman, PrEP and condom use.

Compared to a “reference” case of the risk seen in a non-pregnant, non-post-partum woman aged 25 not on PrEP whose HIV-positive partner had a viral load of 10,000 copies/ml, the adjusted relative risk of HIV transmission during pregnancy or post-partum was 2.76. In other words, pregnancy or being post-partum magnified the risk of HIV infection nearly threefold, independent of other factors, and this was highly statistically significant (very unlikely to be a chance observation).

The relative risk compared with the reference case was 2.07 in early pregnancy, 2.82 in later pregnancy and 3.97 post-partum. Although in these subcategories, the confidence intervals were rather wide, they were still statistically significant and suggest the greatest risk of all – nearly four times normal – may come during lactation. This increased risk was independent of the fact that sexual frequency and condomless sex decreased as pregnancy progressed.

Presenter Renee Heffron at the University of Washington – Seattle, said that although obviously there were hormonal changes in women’s bodies during pregnancy and lactation that probably explained the higher susceptibility to HIV infection, more research was needed to establish the exact risk. The mechanisms may be similar to the higher risk of HIV infection and transmission seen in women who use hormonal contraceptives in some, but not all, studies. Heffron recommended that women receive counselling about the substantially increased risk during this period and that more research is needed to elucidate its cause.

Asked whether PrEP ought to be recommended for women during pregnancy and post-partum, Professor Wafaa El-Sadr of Columbia University’s Mailman School of Public Health, chair of a press briefing on the study, commented that “maybe recommendations should say (PrEP) should be used given the very high risk in this population.”

In many settings with high HIV prevalence, fertility rates are also high and women spend a significant proportion of their reproductive years pregnant, postpartum, or breastfeeding. Some, but not all, studies have demonstrated significantly higher HIV incidence during pregnancy. Per sex act analyses contribute an understanding of the absolute and relative risks of HIV transmission, and can provide insight into whether increased risk during pregnancy and postpartum is attributable to biological or sexual behavior changes. These data are critical to inform the delivery of HIV prevention interventions for women.
2,751 African HIV serodiscordant couples with HIV uninfected female partners were followed prospectively for ≤48 months in two HIV prevention studies. Sexual frequency and condom use was reported monthly. HIV and pregnancy testing occurred monthly or quarterly depending on the study. Study time was categorized by reproductive stage as early pregnancy, late pregnancy, up to 6 months postpartum, or non-pregnant. HIV events that could not be linked between study partners by genetic sequencing were excluded. We used a complementary log-log model to compare the probability of male-to-female HIV transmission per sex act by reproductive stage. The reference case for HIV transmission probability is a condomless sex act between a 25 year old woman not using PrEP and a male partner with HIV RNA of 10,000 copies/ml.
Pregnancy incidence was 12.50 per 100 woman-years (95% CI: 11.52-13.55) and 82 HIV transmission events occurred. The HIV transmission probability was 1.05 per 1,000 sex acts when women were not pregnant, 2.19 in early pregnancy, 2.97 in late pregnancy, and 4.18 in postpartum women (Figure). After adjustment for condom use, age, use of PrEP, and HIV viral load, the probability of HIV transmission per sex act was significantly higher in late pregnancy (aRR 2.82, p=0.01) and postpartum (aRR 3.97, p=0.01) compared to non-pregnant time.
The risk of HIV transmission per sex act steadily increased through pregnancy and was highest during postpartum, even after accounting for sexual behavior, PrEP, and HIV viral load, suggesting that biological changes during these periods increase HIV risk. While further research is needed to better understand biological susceptibility, scale-up of HIV prevention and testing in antenatal and postpartum care in high HIV prevalence settings is warranted to prevent sexual transmission and identify acute maternal HIV infections.

Kerry A Thomson, James P Hughes, Jared Baeten, Grace John-Stewart, Connie L Celum, Craig R Cohen, Nelly R Mugo, James Kiarie, Renee Heffron

Aidsmap material
CROI 2018 abstract

Receive Medical Brief's free weekly e-newsletter

Related Posts

Thank you for subscribing to MedicalBrief

MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.

Thank you for taking the time to complete the form.